Introduction
Secondary infections or co-infections are commonly identified in severe
influenza and also other severe respiratory viral infections with high
mortality and morbidity rate [1]. Co-infection between SARS-CoV-2
and other pathogens have become another serious threat in the treatment
of patients which should not be neglected [2]. These co-pathogens
are including bacteria, such as Streptococcus pneumoniae andStaphylococcus aureus, fungal pathogens includingAspergillus or Mucorales species and also viruses such as
influenza, and rhinovirus/enterovirus [3]. Herein we report the
first case of concomitant aspergillosis, mucormycosis, cytomegalovirus
(CMV) pneumonia and also klebsiella pneumoniae empyema as the
complication of COVID-19 infection who had a favorable clinical outcome.